Aura Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $2,056 | $2,056 | $0 |
Gross Profit | -313 | -306 | 1,732 | -400 |
EBITDA | -22,449 | -22,007 | -24,459 | -18,512 |
EBIT | -22,762 | -22,313 | -24,502 | -18,912 |
Net Income | -20,337 | -19,706 | -22,131 | -18,512 |
Net Change In Cash | 0 | 2,056 | 2,056 | 0 |
Free Cash Flow | -16,653 | -24,540 | -17,704 | -15,493 |
Cash | 30,075 | 26,279 | 41,082 | 55,584 |
Basic Shares | 49,548 | 49,451 | 44,436 | 38,185 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,295 | -1,177 | -835 | -831 |
EBITDA | -83,696 | -59,968 | -35,236 | -21,375 |
EBIT | -84,991 | -61,145 | -36,071 | -22,206 |
Net Income | -76,408 | -57,231 | -34,421 | -22,209 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -26,841 | 131,724 | ||
Free Cash Flow | -64,556 | -55,695 | -34,535 | -25,092 |
Cash | 41,082 | 121,582 | 149,063 | 17,393 |
Basic Shares | 39,620 | 29,937 | 29,211 | 29,219 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.41 |
2024-03-31 | -$0.40 |
2023-12-31 | -$0.56 |
2023-09-30 | -$0.48 |
